Antiemetic Drugs Market By Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Antiemetic Drugs Market
Antiemetic Drugs Market Analysis: By Type of Drug (5-HT3 receptor antagonists, Dopamine antagonists, Steroid-Corticosteroids, Benzodiazepines, NK1 receptor antagonist, Antihistamines, Cannabinoids, Anticholinergic); By Application– With Forecast (2016-2021)
Report Code : HCR 0141
Published: 16 March, 2016   No. of pages: 133

  • Report Description
  • Table of Contents
  • Customization Options
Antiemetic drugs are those that have the ability to treat conditions such as nausea and vomitting. They can be used to treat the aforementioned conditions caused by a range of illnesses. Chemotherapy for cancer patients, food poisoning, gastroenteritis, motion sickness and so on can be treated by antiemetic drugs. In case of pregnant women, these drugs bring significant relief to women who have to endure bouts of morning sickness, either during the early phase of the pregnancy. For some women, the morning sickness lasts for much longer and antiemetic drugs are extremely useful in such situations.

Increasing number of people being affected with different types of cancer is another factor driving the growth of the antiemetic drug market. Chemotherapy is one of the standard treatments used to deal with cancer and is also accompanied by side effects of nausea and vomitting. In fact, chemotherapy actually accounts for the largest share of all the applications of the global antiemetic drugs market.

The time to market and the limited resources for clinical trials and animal testing a factors that are inhibiting the growth of this market. There is a lot of funding devoted to research and development efforts and this can negate some of the growth inhibitors of the antiemetic drug market.
 
Antiemetic Drugs Market

The Antiemetic Drugs market can be segmented on the basis of type of drug as
  • 5-HT3 receptor antagonists
  • Dopamine antagonists
  • Steroid-Corticosteroids
  • Benzodiazepines
  • NK1 receptor antagonist
  • Antihistamines
  • Cannabinoids
  • Anticholinergic 


In terms of applications, the Antiemetic Drugs market has been segmented across the following
  • Chemotherapy
  • Pregnancy
  • Motion Sickness
  • Food Poisoning
  • Gastroenteritis
  • Diziness
  • General Anesthetics
  • Opiod Analgesics
  • Emotional Stress 

North America followed by Europe currently dominates the global antiemetic drugs market and this trend is anticipated to hold good till the end of the forecast period considered in this report. In Asia Pacific, the rapidly increasing population has the potential to further increase the growth of this market. There is also a general increase in several lifestyle related diseases across the world and this can also potentially drive the growth of this market. 

The market has been segmented based on the following geographies:
  • North America
  • South America
  • APAC
  • Europe
  • Middle East 
  • Africa

The antiemetics drug market is highly competitive. Following are just a few of the companies that are operating in the Antiemetic Drugs market:
  • Baxter International
  • Novartis AG
  • Johnson and Johnson
  • GlaxoSmithKline Plc 
  • Cipla Ltd.
1. Antiemetic Drugs– Market Overview
2. Executive Summary 
3. Antiemetic Drugs– Market Landscape 
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Antiemetic Drugs– Market Forces
   4.1. Market Drivers 
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Antiemetic Drugs Market 
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers 
      4.4.3. Threat of New Entrants 
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Antiemetic Drugs Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis 
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Antiemetic Drugs Market– By Type of Drug
   6.1. 5-HT3 receptor antagonists
   6.2. Dopamine antagonists
   6.3. Steroid-Corticosteroids
   6.4. Benzodiazepines
   6.5. NK1 receptor antagonist
   6.6. Antihistamines
   6.7. Cannabinoids
   6.8. Anticholinergic 
   6.9. Others
7. Antiemetic Drugs Market– By Application
   7.1. Chemotherapy
   7.2. Pregnancy
   7.3. Motion Sickness
   7.4. Food Poisoning
   7.5. Gastroenteritis
   7.6. Diziness
   7.7. General Anesthetics
   7.8. Opiod Analgesics
   7.9. Emotional Stress 
   7.10. Others
8. Antiemetic Drugs Market– By Geography
   8.1. Introduction
   8.2. Global Study
   8.3. Americas
      8.3.1. North America 
      8.3.2. Brazil
      8.3.3. Argentina
      8.3.4. Others 
   8.4. Europe
      8.4.1. U.K.
      8.4.2. France
      8.4.3. Germany
      8.4.4. Others
   8.5. APAC
      8.5.1. China
      8.5.2. Japan
      8.5.3. India
      8.5.4. Others
   8.6. ROW
9. Antiemetic Drugs Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles 
   10.1. GlaxoSmithKline
   10.2. Pfizer Inc.
   10.3. Johnson and Johnson
   10.4. Astellas Pharma
   10.5. Merck
   10.6. Sanofi-Aventis
   10.7. Baxter International
   10.8. Abbott Labs
   10.9. Cipla Ltd.
   10.10. Novartis AG
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports